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Abstract 
 
Ultrasound-vaporizable microdroplets can be exploited for targeted drug delivery. However, it requires customized 
microfluidic techniques able to produce monodisperse, capillary-sized and biocompatible multiple emulsions. 
Recent development of microfluidic devices led to the optimization of microdroplet production with high yields, 
low polydispersity and well-defined diameters. So far, only few were shown to be efficient for simple droplets or 
multiple emulsions production below 5 microns in diameter, which is required to prevent microembolism after 
intravenous injection. Here, we present a versatile microchip for both simple and multiple emulsion production. 
This parallelized system based on microchannel emulsification was designed to produce perfluorocarbon in water 
or water within perfluorocarbon in water emulsions with capillary sizes (<5 μm) and polydispersity index down 
to 5 % for in vivo applications such as spatiotemporally-triggered drug delivery using Ultrasound. We show that 
droplet production at this scale is mainly controlled by interfacial tension forces, how capillary and viscosity ratios 
influence droplet characteristics and how different production regimes may take place. The better understanding 
of droplet formation and its relation to applied pressures is supported by observations with a high-speed camera. 
Compared to previous microchips, this device opens perspectives to produce injectable and biocompatible droplets 
with a reasonable yield in order to realize preclinical studies in mice. 
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TEXT 
 
Introduction 
 
Drug-delivery is a vast domain of research and it allows to envision more efficient treatments with reduced side-
effects. It often implies the intravenous injection of carriers designed to be activated specifically in disease targets, 
such as cancerous tumors. Targeted drug-delivery can be performed with ultrasound, which can be focused with a 
submillimetric precision deep inside the body and can trigger the release or the disruption of acoustically-sensitive 
agents (Couture et al. Review 2014). This concept has shown enormous potential for the delivery of drugs (Gao et 
al. 2004), DNA (Suzuki et al. 2007) or dyes (Fokong et al. 2012). 
 
As micrometric bubbles couple very efficiently with ultrasound (MHz range) to produce various mechanical and 
thermal local effects, several drug-delivery agents designed around microbubbles or gas-precursor droplets were 
conceived. A promising in vivo application is acoustic droplet vaporization (ADV) where microdroplets follow a 
liquid-to-gas phase shift, leading to the formation of large bubbles (around 25 μm), transiently occluding local 
microvasculature (Lin & Pitt 2013; Sheeran & Dayton 2014) and locally delivering its content (Couture et al. 2011 
& 2012; Bezagu et al. 2014). Recently, a new way of realizing ADV, called acoustic cluster therapy (Sontum et 
al. 2015; van Wamel et al. 2016 a & b) has emerged and proven its efficiency to enhance vasculature permeability 
and extravasation of co-injected therapeutics (van Wamel et al. 2016b; Park 2016). 
 
As described by our group (Couture et al. 2011 & 2012; Bezagu et al. 2014) and others (Fabiilli et al. 2014), a 
particular subclass of ultrasound-vaporizable agents are composite microdroplets. They are formed by a 
nanoemulsion of water in perfluocarbon (PFC), itself encapsulated in micron-sized droplets. The PFC forming the 
matrix of droplets can be vaporized by a microsecond-duration ultrasound pulse, hence destabilizing the droplet 
and allowing the inner and outer water phase to mix. We chose perfluorohexane (PFH) for its phase transition 
properties: as it vaporizes at 58°C, it allows us to produce stable emulsions at room temperature while its 
vaporization remains possible using clinical ultrasound devices. Moreover, these droplets also have the advantage 
to carry large payloads in each droplet and isolate the inner phase from the exterior through a hydrophobic and 
lipophobic PFC matrix. However, these composite droplets need to be sufficiently large, at least a few microns in 
diameter, to contain efficiently the nanoemulsion.  
 
Conversely, before being activated by ultrasound, these composite droplets, like any intravenous drug-delivery 
carrier, need to be circulating. For agents injected intravenously, the upper size limit is that of the capillary 
diameter in order to prevent embolization of the microvasculature. A study of Wiedeman et al (1963) summarizes 
the diameter of capillaries in numerous species. In healthy human, normal capillaries have diameters ranging from 
5 to 12 μm (Landau & Davis 1957). Earlier works showed that capillaries are 3.0 to 10.0 μm wide (Zweifach 1937) 
or that arterioles, capillaries and venous capillaries are about 5.0 or 6.0 μm in mice (Algire 1954). 
 
Hence, in our view, having microdroplets of less than 5 μm is necessary for in vivo applications in order to 
efficiently reach peripheral circulation, avoid embolism and remain vaporizable by a clinical ultrasound scanner. 
Moreover, tightly monodispersed population of ultrasound-inducible particles were shown to be favorable as a 
therapeutic tool (Choi et al. 2010) and also make the therapeutic effect more predictable (Hingot et al. 2016). 
Unfortunately, producing uniform composite emulsions below 5 microns in diameter and in sufficient quantities 
for injection remains extremely challenging. 
 
In previous works, microdroplets were prepared using microfluidic device in polydimethylsiloxane (PDMS), 
mixing flow-focusing and step emulsification as proposed by Cohen et al (2014). We also developed similar 
parallelized systems to enhance production rate (Cohen et al. 2014). However, simple systems had a low yield of 
production (less than 2500 droplets per second, while in vivo applications require around 108 injectable 
microdroplets per mice) and parallelized ones were too sensitive to pressure conditions. This is especially critical 
as we need to inject a nano-emulsion inside the device if we desire multiple emulsions. This nano-emulsion of 
water in PFH has a mean hydrodynamic diameter of 230 nm and cannot be filtered before injection into a 
microfluidic device (Couture et al. 2012). Thus, any impurity or dust may clog some channels, leading to the 
unproductivity of the concerned system, an increase of pressure inside other channels and eventually a 
destabilization of the global production. Furthermore, PDMS has some drawbacks such as unstable wettability and 
a low robustness. 
 
These issues could be solved through the numerous new developments in the field of microdroplet and microfluidic 
technologies. Progresses have been mostly driven by research in cosmetic or food science where production 
efficiency, monodispersity and stability remain the most important parameters (Zhu & Wang 2017; Lee et al. 2016; 
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Shang et al. 2017). Advances in these requirements were achieved through optimization of geometry of droplet 
production systems and adequate control of physico-chemical parameters such as wetting and shear rate, both for 
simple and multiple emulsion production (Zhu & Wang 2017; Lee et al. 2016; Shang et al. 2017). Some works 
aim at producing droplets for biological research (chemical synthesis and analysis, screening, enzyme kinetics, 
cell culture and sorting, protein crystallization (de Mello 2006; Janasek et al. 2006; Bezagu et al. 2014)) or drug 
encapsulation and delivery (Shang et al. 2017; Koster et al. 2008; Song et al. 2006). Many papers reported the 
efficient production of simple emulsions (up to 1.4 liters per hour) (Kobayashi et al. 2012) or monodisperse 
multiple emulsions (Kawakatsu et al. 2001; Utada et al. 2005), or even thermo-, chemo- or photo-triggered delivery 
with multiple emulsions (Lee et al. 2016). Yet, only few achieved the production of microdroplets compatibles 
with intravenous delivery (< 5 μm) with a low polydispersity as well as reasonable production rates. 
 
In general, most microfluidics droplets production systems may be separated in three kinds: co-flow, cross-flow 
and flow-focusing geometries. These three methods allow the production of well-defined droplets depending on 
hydrodynamic parameters. However, the change of a parameter leads to the modification of droplets 
characteristics. Another technique as micropipetting solves this problem using gravity as an external force 
balancing interfacial tension (Christopher & Anna 2007). Yet, this technique is not suitable for micrometric 
dimensions as gravity becomes negligible compared to interfacial tension and viscous forces (Dangla et al. 2013). 
 
Nakajima’s team introduced many microfluidic systems allowing the production of droplets without the necessity 
of fine-tuning hydrodynamic parameters, and especially shear, by adapting microchip geometry and dimensions 
(Sugiura et al. 2002a; Kobayashi et al. 2005, van Dijke et al. 2010). These systems are based on the use of 
microchannels (MC) with defined dimensions coming out on large rivers with terraces (Fig. 1). The terrace drives 
the confinement of liquid between two horizontal walls. Once the liquid reaches the border of the terrace, it starts 
pulling itself outward, resulting in the formation of a spherical droplet with a lower superficial energy in the outer 
channel (Fig. 1). This method called MC emulsification has many advantages: the flow rate in MC and outer 
channel only have to be approximately defined; MC may be parallelized to obtain higher yields; geometry can be 
adapted to obtain desired droplet sizes and it requires a low energy input compared to other emulsification 
techniques (Sugiura et al. 2001). Indeed, droplet formation is the consequence of interfacial tension, the 
dominating force at this scale, which is itself consequent of the microchip geometry (Sugiura et al. 2001). Such 
spontaneous droplet formation devices enable the production of droplets with low dispersity, good yields (if there 
is parallelization), easy handling and robustness. Even if MC emulsification is less dependent on hydrodynamic 
parameters, some viscosity and flow rate considerations are needed in order to succeed in stable microdroplet 
production. Not only the design of the microchip is important, but it needs to be adapted to the characteristics of 
fluids that are used. 
 
 
Fig. 1 When escaping MC, the disperse phase follows first an inflation process when a pancake-like droplet is 
created on the terrace (left). In this confined space, the radius of droplet curvature is high, the droplet is in an 
unfavorable energy state as a spherical shape is desirable to lower interfacial tension. The pancake grows and 
eventually reaches the border of the plateau. There, interfacial tension is higher inside the terrace than outside. 
This energy imbalance will pull the droplet out into the deeper channel to transform into the more favorable 
spherical shape (right) 
 
Terrace production happens if interfacial tension force is important enough compared to inertial and viscous forces. 
This mechanism was proposed by Sugiura et al. (2000) and suggest the importance of terrace dimensions on final 
droplet size. Indeed, the higher the plateau the lower the radius of droplet curvature inside the terrace and the 
harder and later the detachment of droplets. According to the literature (Sugiura et al. 2002a; Shui et al. 2011), 
droplet diameters have low dependency on terrace length but are proportional to terrace height. It was also shown 
that droplet diameter is proportional to the smallest slit dimension (in our case, terrace height) to a factor between 
3.2 (Kobayashi et al. 2005) and 6.88 (Sugiura et al. 2002a) depending on the viscous ratios of the two phases (van 
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Dijke et al. 2010). Indeed, for a given terrace dimension, droplet size will be influenced by the viscosity ratio 𝜀 of 
the two liquids (Equation 1). In this equation, the viscosities of disperse and continuous phases are denoted ηd and 
ηc (Pa.s), respectively.  
 
𝜀 =
𝜂𝑑
𝜂𝑐
     (1) 
 
With a less viscous disperse phase, droplets have a larger diameter in the same continuous phase due to an increase 
of flow velocities at the exit of MC (Kawakatsu et al. 2001; Kobayashi et al. 2005). Van Dijke et al. (2010) 
proposed that a minimal viscous ratio is necessary to produce droplets and that a critical ratio exists above which 
droplet size is not anymore influenced by viscosity. Other studies proposed that this is the consequence of 
surfactant depletion around the future droplet: if the continuous phase is too viscous compared to disperse phase, 
droplets will form too rapidly compared to the necessary time for surfactant molecules to diffuse and adsorb on 
newly formed interfaces, destabilizing formed droplets (van Dijke et al. 2010; Vladisavljevic et al. 2011). These 
ratios seem device-dependent: their initial microfluidic system has a minimal viscous ratio of 0.48, but smaller 
terrace dimensions lead to a minimal ratio of 0.16. To explain this phenomenon, we propose that decreasing terrace 
dimension leads to a decrease of flow velocity at the exit of MC and an increase of interfacial tension force 
compared to inertial and viscous force, therefore permitting droplet production with a less viscous disperse phase.  
 
All these studies convinced us of preferring MC microfluidic technologies that less rely on fine fluid flow tuning 
than what we previously developed. In this study, we introduce an appropriate microfluidic system for producing 
biocompatible PFH in water (PFH/W) or W/PFH/W ultrasound-vaporizable microdroplets. Our general aim is to 
develop new ultrasound-sensitive carriers to release active substances at a desired spot in vivo. We therefore 
developed a new design of parallelized microfluidic device taking advantage of MC and rupture confinement 
where the MC are fed and disposed through pressurized rivers (Couture et al. 2017; Martz et al. 2011). Glass 
lithography was preferred to PDMS in order to stabilize wetting properties and have robust and long lifetime 
microchips (Fabiilli et al. 2014). First, we present the production behavior of this device with a simple emulsion, 
before considering producing multiple emulsions. In both case we characterize obtained emulsions for given flow 
parameters and we try to understand phenomena that are responsible for changes in production regimes of this 
new device. Lastly, we need to ascertain that droplets vaporize easily using a clinical echograph. Thus, we ensured 
that we were able to realize ADV in vitro in the same conditions as with our previous microdroplets. 
 
 
Material and methods  
 
Chemicals: 
 
The water phase was made fluorescent by dissolving fluorescein sodium salt (Sigma–Aldrich Chemie GmbH, 
Germany) in mQ water at a final concentration of 1% (w/v). Glycerol (Amresco, USA) has been used to tune the 
water phase viscosity from 1 to 2.74 mPa.s (30 wt%). Surfactants have been used to stabilize generated droplets. 
The surfactants used were PEG-diKrytox (3% w/v in PFH) (Ran Biotechnologies, USA) and Poloxamer P188 (3% 
w/v in mQ water) (Sigma–Aldrich Chemie GmbH, Germany). Ultrasound vaporizable property of microdroplets 
was achieved using perfluorohexane (Acros Organics, USA) as the water non-miscible phase. Microchips were 
manufactured by Micronit Micro Technologies B. V. (Enschede, The Netherlands). 
 
Microchip design: 
 
While we previously used PDMS microchip (Couture et al. 2011; Couture et al. 2012), we favored for this study 
glass lithography to have robust and long lifetime devices, as well as a good reproducibility and steady wetting 
properties. Nanochannels and MC were etched into a borosilicate glass wafer. The connection holes were drilled 
in a second borosilicate glass wafer using powder blasting techniques. Subsequently, these two wafers were 
aligned and thermally bonded together. The proposed microchips consist of two millimeter-deep rivers linked by 
225 MC. MC parallelization has many advantages for the production of microdroplets: not only it allows 
production increase, but the clogging of one or few MC has no significant influence on the production of others. 
This is critical for producing W/PFH/W microdroplets as we inject a nano-emulsion of water in PFH, which we 
cannot formerly filter, inside these MC (Fig. 2). This potential clogging also justifies the use of the two parallel 
rivers, which remove dust particles before they are injected in the MC. A microfluidic flow control system (MFCS-
EZ, Fluigent, France) was used to drive the liquid flows through the microchip. This set-up is hence entirely 
confined and the only communications between fluids and atmosphere are at the entrance of the flow control 
system and at the continuous phase outlet. 
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Fig. 2 Schematic representation of our microfluidic device. Left: representation of millimeter-wide channels (red) 
and MC in between (blue). Continuous phase is flowing from inlet number 1 to outlet number 4 and disperse phase 
alternatively from 2 to 3 or 3 to 2. Pressures are controlled so disperse phase also goes through MC. Right: Side 
and top views of the production system. Schemes are not at scale: H = 0.1 mm and W = 1 mm, while MC and 
terrace height are 0.6 and 0.8 μm, respectively 
 
The system is not symmetric: one channel (considered as the ‘inner’ channel) is made to receive the disperse phase, 
while the other one (the ‘outer’ channel), where the terrace is, is made to receive the continuous phase (Fig. 2). 
 
In the proposed device, the two rivers are pressurized on both the inlet and the outlet. The flow in each river is 
determined by the pressure gradient between the inlet and outlet. Conversely, the flow inside MC between the two 
rivers is determined by the pressure gradient between the two inlets. Such system, with 4 pressurized containers 
allow the production to be entirely confined, except for the flow of air from the 4-channel pressurization system. 
Moreover, it allows a full automatization since the flow of the rivers can be inverted and the production can be 
performed in both directions. Applied pressure at the inlet number 1 corresponds to the external phase and will 
therefore be named ‘‘external pressure’’ while applied pressures at disperse phase inlets/outlets will be later named 
‘‘internal pressures’’. 
 
Considering geometry of previously described MC emulsification systems, we chose 250 μm long, 4.2 μm wide 
and 0.6 μm high MC and a slightly higher terrace (0.8 μm). Long MC are in favor of a more stable production of 
droplets (van Dijke et al. 2010; Sugiura et al. 2002b) and terrace height is linked to the desired droplet radius. 
Schematically, we can evaluate the final droplet volume by the terrace dimensions: as the liquid spread on the 
terrace in a disc-like shape, we chose dimensions so the volume contained in such a disc is the same as contained 
in a 4.0 μm diameter droplet (Equation 2). 
 
𝑅𝑑 = √
3
16
𝐻𝐿2
3
     (2) 
 
H and L represent terrace height and length, respectively. Using Sugiura et al. predictive equation linking droplet 
diameter to terrace dimensions (Sugiura et al. 2002a) we find a predicted diameter of 4.8 μm, which is comparable 
to our simple estimation. As we will develop later, we experimentally obtained droplets with diameters ranging 
from 3.2 to more than 9 μm, depending on experimental conditions (characteristics of disperse and continuous 
phases, applied pressures). 
 
Droplet formation observations: 
 
We visualized microdroplet formation process using a set-up constituted of an inverted microscope (DMIL LED, 
Leica Microsystems) with a high-speed camera (Phantom v12.1, Vision Research, Ametek) and observations are 
consistent with the inflation and detachment model described in the introduction (Fig. 3): 
 6 
 
 
Fig. 3 PFH microdroplet formation at the exit of a single MC (out of 225). Inflation phase: as PFH flows out of 
the MC on the terrace, a disc-like droplet is created. Detachment phase: once it reaches the border of the terrace, 
interfacial tension force pulls the droplet out of the terrace (white arrow), leaving a residual amount of disperse 
phase on the terrace (right image). Time at which photos were taken is written above each photo, pressure 
difference between internal and external channel is 50 kPa, scale bar represents 10 μm (104 fps) 
Imaging this phenomenon gives the opportunity to measure the mean time between detachment of successive 
droplets in order to calculate mean flow velocity inside MC while changing pressures conditions. This will be 
further used to better characterize droplet production. 
 
Emulsion production and characterization: 
 
Production of simple PFH/W microdroplets was achieved by pushing pure PFH through MC, while using a 3% 
(w/v) P188 aqueous solution as the continuous phase. In order to obtain double emulsion droplets, our strategy 
was to first produce a nano-emulsion of water (containing 1% (w/v) fluorescein) in PFH before proceeding to a 
second emulsification using our micro-chip. First, the disperse phase was obtained using a Branson Sonifier 450 
ultrasonic tip (Branson Ultrasonics, USA). Then, the disperse phase was pushed through the MC, as with the PFH 
in the first part of this study. 
Droplet sizes and PDI were characterized by taking pictures after depositing 50 μL of a droplet solution in a p96 
well. 4 photos of each well were taken with an inverted microscope (DMIL LED, Leica Microsystems) and size 
distributions were analyzed with a home written Matlab script (MathWorks, USA). At least three productions and 
analysis were realized for each condition. 
 
Capillary number determination: 
 
Determining mean diameters allows to calculate mean volume exiting MC per second and hence, disperse phase 
mean velocity and mean capillary number inside MC. Continuous phase velocity also depends on applied pressure. 
Calibration was realized measuring volume exiting the microchip for a given duration and applied pressure. 
Viscosities of PFH (6.70 mPa.s) and P188 water (1.66 mPa.s) and glycerol/water (1, 1.42, 1.84, 2.74 mPa.s for 0, 
10, 20 and 30 % w/v, respectively) solutions were taken or calculated from the literature (Liu et al. 2011; Takamura 
et al. 2012) as well as interfacial tension of PFH against water (3.35 mN.m-1) (Xiaonan et al. 2017). 
 
Acoustic droplet vaporization: 
 
A culture plate with 50.106 microdroplets dispersed in 10 mL of glycerol in water (30% w/w, mimicking blood 
viscosity) is placed both at the focal distance of an acoustic transducer and a macroscope (x8). 2 μs acoustic pulses 
with various intensities were emitted while optic monitoring of droplet vaporization was realized. 
 
 
Results and discussions 
 
Simple emulsion production and size dependence with hydrodynamic or physicochemical parameters: 
 
We first produced PFH/W microdroplets: we tested our microfluidic system with a large range of applied pressures 
both for inner and outer channels. It remains functional if inner channel pressures remained superior to outer ones 
and as long as the pressure difference is sufficient to observe droplet formation. Fig. 4 gives information about the 
dependence between droplet diameters, polydispersity index (PDI), applied pressures and hence flow velocities. 
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Fig. 4 Diameters and PDI of PFH/W emulsions: characteristics of microdroplets produced with different applied 
pressures for simple emulsions of PFH in water. Diameters and PDI values are represented by blue and red circle 
diameters, respectively, while standard deviations are proportional to line widths (n3 for each condition). 
Diameters, PDI and standard deviations (written in brackets) are also displayed in number format on the top of 
each circle 
On Fig. 4, we clearly see a trend between microdroplet characteristics and applied pressures. The higher P, the 
bigger diameters and PDI. This is particularly obvious for an external pressure of 0.2 bar and internal pressures 
from 1 to 4 bars (lower circles on Fig. 4). Conversely, for a set internal pressure, increasing external pressure leads 
to smaller droplets and a lower PDI (see circles for 3 or 4 bars as internal pressures). Furthermore, we see that very 
close droplet diameters and PDI are obtained for different applied pressure. For instance, there is no significant 
difference between droplet characteristics produced at following internal/external pressure pairs (given in bars): 
1/0.2, 2/1.5 and 3/2.5 or 3/1.5 and 4/2.5. Production rates range from 4 to 43.106 droplets.min-1 depending on 
applied pressures (Fig. 5). 
 
 
Fig. 5 Production rate of PFH/W emulsions: amount of microdroplets produced with different applied pressures 
for simple emulsions of PFH in water. Production rate is proportional to circle diameters, while standard deviation 
is proportional to line width 
For a given external pressure, increasing internal pressure leads to an increase of production rate, which is quite 
intuitive. However, one could think that increasing external pressure while keeping internal pressure constant 
would lower production rate, as pressure difference would decrease. Interestingly, for a given internal pressure, 
the production rate is at its lowest value when external pressure is low (0,2 bar). This is rather counter-intuitive 
but is explained by the fact that at these pressures, as droplet diameters is higher, much less droplets are produced 
for a volume of PFH exiting MC. Stolovicky et al. (2018) recently showed that for high rate of droplet production, 
they may accumulate where they form and interfere with next droplets to form and lead to an increase of diameter 
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and PDI. In our case, this is more precisely due a coalescence phenomenon which will be discussed in the following 
paragraphs. A solution is to take away newly formed droplets, which is easy to realize with our design by applying 
a higher external pressure, inducing a higher continuous phase flow rate. 
 
Fig. 6 illustrates the consequence of applying various pressures on obtained microdroplet characteristics. Three 
examples were chosen to visualize the evolution of microdroplet populations. Applied P increases from left to 
right (0.5, 1.8 and 3.8 bars, respectively). In the first condition (P = 0.5 bar, Fig. 6.a), the droplet population is 
homogeneous (PDI = 5.4 %) with the desired mean diameter. In the second condition (P = 1.8 bar, Fig. 6.b), 
droplets still have a relatively low droplet diameter (< 10 μm) but became very heterogeneous (PDI = 45 %). With 
the highest P (3.8 bars, Fig. 6.c), mean diameter gets closer to 10 μm, leading to unwanted sizes for in vivo 
applications. 
 
 
Fig. 6 PFH microdroplet population diameters and PDI for various applied pressures. Internal/external pressures 
were set to 3/2.5 (a), 2/0.2 (b) and 4/0.2 (c) bars. Histograms of size distributions are represented next to 
representative pictures of microdroplets obtained at corresponding conditions. Scale bars represent 10 μm 
 
Fluid flows in capillaries may be characterized using capillary numbers for disperse (Cad) and continuous (Cac) 
phases. Capillary number is the ratio between viscous and interfacial tension forces. Defining  (Pa.s) as the fluid 
viscosity, U (m.s-1) as the mean fluid velocity and  (N.m-1) as the interfacial tension, capillary number is defined 
as follows: 
 
𝐶𝑎 =
 ∗ 𝑈

     (3) 
 
As both internal and external pressure seem to influence the characteristics of produced droplets, it is relevant to 
introduce a ratio comparing flow properties at the exit of MC. Capillary number ratio, as well as flow rate ratio, 
may be used for this purpose. Using previously introduced abbreviations, we can determine that capillary number 
ratio is proportional to velocity ratio: 
 
𝐶𝑎𝑑
𝐶𝑎𝑐
=

𝑑
∗ 𝑈𝑑

𝑐
∗ 𝑈𝑐
= 𝜀 ∗
𝑈𝑑
𝑈𝑐
     (4) 
 
Fig. 7 shows that there is a linear relationship between droplet diameters and capillary number ratio. However, the 
correlation is low for PDI as we observe the apparition of a plateau (Fig. SI 1). 
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Fig. 7 Mean PFH droplet diameter as a function of capillary numbers ratio 
 
Many papers recently described systems that were relying on the geometry of the device to define droplet sizes 
(Sugiura et al. 2002a; van Dijke et al. 2010; Shui et al. 2011; Vladisavljevic et al. 2011). Yet, interestingly and 
similarly to our results, they obtain a high polydispersity and higher sizes when the inner phase flow rate increases 
(Shui et al. 2011; Vladisavljevic et al. 2011; Amstad et al. 2016). In a related manner to Fig. 7, they describe 
production regimes depending on the fluid velocity inside MC. Below a critical velocity Ucr, interfacial tension 
forces predominate and droplet diameter is constant (dripping regime) (Sugiura et al. 2002c), but above Ucr the 
sum of viscous and buoyancy forces dominates over interfacial tension force and previous studies report a 
continuous flow of disperse phase, forming a big droplet at the MC exit (blow-up mode) (Vladisavljevic et al. 
2011). Conversely to dripping mode, the droplet size become independent of the geometry of the microchip in 
blow-up regime. In our case, the critical velocity corresponds to a capillary ratio around 5-7.10-7. Furthermore, the 
production of microdroplets with a high polydispersity and higher sizes also happens when continuous phase 
viscosity increases and consequently continuous phase flow decreases (van Dijke et al. 2010). Thus, we assessed 
the influence of continuous phase viscosity on droplet characteristics. We tuned the viscosity by adding 0, 10, 20 
or 30 % (w/v) of glycerol to the aqueous phase. For given applied pressures, the only visible consequence was a 
decrease of continuous phase velocity and, in turn, an increase of PDI and droplet mean diameters (Fig. SI 2). 
Indeed, if PDI and mean diameters are drawn against flow rate ratio (which is proportional to the capillary number 
ratio divided by the viscosity ratio), differences between each condition almost disappear (Fig. SI 3). This is 
consistent with the fact that flow velocity in outer channel is inversely related to fluid viscosity and it suggests that 
viscosity do not have a strong influence on droplet size if flow rate remains constant. 
 
Interestingly, in our situation, we see that droplets that detach from the terrace are of similar dimension, and that 
increase in size is the consequence of coalescence of small droplets when they form too close to each other. This 
is much different from previously described similar but larger production devices which suggest the straight 
formation of larger droplets at the exit of MC (van Dijke et al. 2010; Vladisavljevic et al. 2011). Using a high-
speed camera and decreasing the surfactant concentration by 100 times, we were able to unveil the underlying 
phenomenon responsible for the apparition of larger droplets (Fig. 8). This also explains why increasing external 
pressure, and thus continuous phase velocity, allows the production of smaller droplets: the increased flow in outer 
channels “flushes” formed droplets away, preventing them to remain where they appeared at the exit of MC. 
Additionally, increasing continuous phase velocity may help stabilizing newly formed interfaces by avoiding 
surfactant depletion (van Dijke et al. 2010; Vladisavljevic et al. 2011). 
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Fig. 8 Production of PFH droplets in water with a low concentration of surfactant (0.03 % w/v) and various applied 
pressures. a) Photos were taken at 0, 0.3, 2.3, 6.5, 17.6 and 37.2 ms. b) Photos were taken at 0, 0.5, 3.2, 6, 14 and 
19 ms. c) Photos were taken at 0, 6, 14, 22, 29 and 43 ms. Final mean diameters are 17.7 (a), 14.4 (b) and 11.9 (c) 
μm. a-b) White arrowheads show newly formed small droplets about to coalesce with following ones, leading to 
a new large one. Scale bars represent 10 μm 
Fig. 8 depicts how external pressure (and hence continuous phase velocity) influences droplet size: a low external 
pressure such as 0.2 bar (Fig. 8.a) leads to larger droplets than higher external pressures and flows (Fig. 8.b and 
8.c). The lower the flow, the lower the dragging force applied on droplets. Thus, a larger size is reached before 
droplet detached and flushes away from the exit of MC. Increasing external phase velocity drags smaller droplets 
faster, lessening their final diameter. 
 
This observation is in favor of the statement that confinement rupture is a very stable and efficient technique to 
produce microdroplets with a specific diameter. Indeed, in our case, the phenomenon causing polydispersity 
increase is not related to droplet formation on the terrace but only to an insufficient speed of turnover of continuous 
phase outside the terrace (and also, in the previous experiment, to an insufficient concentration of surfactant). The 
reason why droplets coalesce may be that a high rate of droplet formation at the exit of MC leads to the formation 
of a new interface where surfactant has not enough time to diffuse. As a consequence, this new interface is not as 
stable as when production rate is low and coalescence is favored, as it has already been proposed (van Dijke et al. 
2010; Wang et al. 2009). Nakajima’s team suggested that, for their systems, continuous phase flow may only be 
useful for droplets recovery and do not influence droplet sizes in dripping regime (Vladisavljevic et al. 2011). 
However, for smaller systems as ours, it seems that droplet characteristics are proportional to capillary number 
ratio and hence related to both phase flows. This is converse with previously published results and may be related 
both to special chemicals we use and to the specificity of our microfluidic device. 
 
Our initial aim was to develop a new microfluidic device allowing us to produce efficiently double emulsion for 
in vivo applications. Previously used parallelized systems, merging flow focusing and step emulsification (Cohen 
et al. 2014), were not optimized for this task. Indeed, the water in PFH nano-emulsion could clog some channels, 
leading to significant changes in flow parameters and hence in droplet characteristics. As this nano-emulsion 
cannot be filtered without altering its properties, we needed a system able to remain stable even with clogging of 
some channels. Furthermore, previous systems produced approximately 2500 droplets per second, which lead to 
more than 5 h of production for one mouse, if the production rate remained stable. It was thus crucial for the 
development of preclinical assays to be able to produce intravenously injectable multiple emulsions in sufficient 
amount and reasonable duration. As was demonstrated above, our microfluidic device can stand some pressure 
variations with no significant effect on droplet diameters as long as capillary number ratio do not change much. 
So, we realized a similar study relating pressure conditions to composite microdroplets characteristics. 
 
 
Double emulsion production: 
 
Similarly to simple emulsion production, mean diameters and PDI of multiple droplets were determined for many 
external and internal pressures (Fig. 9). 
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Fig. 9 Diameters and PDI of W/PFH/W emulsions: characteristics of microdroplets produced with different 
applied pressures for double emulsions of water in PFH in water. Diameters and PDI values are represented by 
blue and red circles diameters, respectively, while standard deviations are proportional to line widths (n3 for each 
condition) 
Conversely to PFH/W emulsion, we only observe a slight increase in droplet diameter for two conditions 
corresponding to the highest pressure ratios (4/0.2 and 4/1.5 bars for internal/external pressures). Hence, for 
W/PFH/W droplets, the dripping regime of this production system covers a larger range of pressures than for 
PFH/W emulsion. This may be explained by the fact that the nano-emulsion is more viscous than PFH, leading to 
reduced MC fluid velocities thus mimicking lower internal pressures. Still, high pressure ratios lead to significant 
increases of PDI. As for PFH/W emulsions, high internal pressures do not prevent from producing biocompatible 
droplets with diameters and PDI inferior to 5 μm and 10 %, respectively (for instance internal/external pressures 
of 4/2.5). 
 
Production rates are not significantly different for all pressure conditions (Fig. SI 4) and range from more than 
6000 to 25000 per second for droplets with PDI less than 0.08. This opens new experimental perspectives as we 
are now able to produce enough microdroplets in a half day to treat more than 5 mice, which used to necessitate 
at least two days of production. Furthermore, new microfluidic devices are easy to wash and may be reused for 
hundreds of productions with steady properties while previous PDMS microchip could not be used more than few 
times. 
 
 
Fig. 10 Mean W/PFH/W droplet diameter as a function of capillary numbers ratio 
For multiple emulsion production, similar applied pressures to those used for simple emulsion production lead 
almost all to dripping regime. This is not surprising as the nano-emulsion is more viscous than pure PFH, 
decreasing flow velocity and hence capillary number inside MC. Our system did not allow us to apply higher 
pressures, and observe a larger blow-up regime domain, but diameters suggest it is beginning above capillary ratios 
of 5-6.10-8 (Fig. 10), while PDI of multiple emulsions start to increase around 2.10-8 (Fig. SI 5). We actually 
assessed different lengths of terrace and we eventually chose one which produces monodisperse and capillary sized 
multiple emulsions for our pressure range. Thus, this new microfluidic device has a dripping regime that is 
consistent with pressure we are able to apply (1-4 bars) and for described chemicals. 
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Fig. 11 illustrates the evolution of microdroplet populations for various applied pressures. P increases from left 
to right (1.5, 2.5 and 3.8 bars, respectively). In the first condition (P = 1.5 bar, Fig. 11.a), the droplet population 
is homogeneous (PDI = 5.6 %) with the desired mean diameter. In the second condition (P = 2.5 bar, Fig. 11.b), 
droplets still have the desired droplet diameter (< 4 μm) but became more heterogeneous (PDI = 20 %). With the 
highest P (3.8 bars, Fig. 10.c), mean diameter gets over 4 μm, and PDI increases to 25 %. Still, W/PFH/W have 
sizes and PDI that are much more compatible with in vivo applications than PFH/W emulsions, regardless of 
applied pressures. 
 
 
 
 
Fig. 11 W/PFH/W population diameters and PDI for various applied pressures. Internal/external pressures were 
set to 4/2.5 (a), 4/1.5 (b) and 4/0.2 (c) bars. Histograms of size distributions are represented next to representative 
pictures of microdroplets obtained at corresponding conditions. Scale bars represent 10 μm 
As demonstrated in the literature, the stability of dripping regimes of MC emulsification systems allows easy up-
scaling of monodisperse microdroplet production (Kobayashi et al. 2012). In our situation, for both simple or 
multiple emulsion production, it is still necessary to control these parameters in defined ranges that are specific to 
production condition: microchip dimension and geometry, fluid properties and probably surfactants that are used. 
As we previously observed for PFH/W emulsions, high pressure ratios lead to the formation of larger droplets 
through coalescence phenomena. This is responsible for the increase of mean diameter and PDI and the 
coalescence phenomenon is illustrated in Fig. 12 for double emulsion production. 
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Fig. 12 Observation of the formation of large microdroplets at the exit of MC with at 104 frames per second. 
Internal and external pressures were 3.5 and 0.2 bars, respectively. a-f) Formation of a first large droplet (white 
arrows) which eventually flows away (d) while a new large droplet starts to form (d, black arrows). Photos were 
taken at 0, 4, 8, 32.8, 38.5, 49.7, 56.3, 58.6 and 64 ms (from a to i, respectively). Scale bar represents 10 μm 
 
Ultrasound vaporization: 
 
Using a previously described set-up (Couture et al. 2011; Hingot et al. 2016) we observed in vitro droplet 
vaporization (Fig. 13). Fluorescence of fluorescein is quenched while fluorescein is confined at high concentration 
inside droplets (Nichols et al. 2012). When droplets vaporize, inner aqueous medium is spilled inside external 
water and fluorescein concentration drops, leading to a strong increase of fluorescence (fluorescence of fluorescein 
is approximately decreased 80 times at a concentration of 1%). This increase of fluorescence is seen after the 
ultrasound delivery pulse has been emitted (Fig. 13 middle and right). Even if we change our way of producing 
multiple microdroplets and used device, we kept acoustic vaporization properties of previously described 
emulsions (Hingot et al. 2016). 
 
 
 
Fig. 13 Optical monitoring of acoustic droplet vaporization. Images were taken before (left), 0.5 and 1 s (middle 
and right, respectively) after the focalized ultrasound push (2μs, 5 MHz, 3.1 MPa PnP) was emitted 
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Conclusion 
 
An innovative design merging MC and step emulsification has been developed in order to overcome limitations 
we were facing when producing intravenous injectable multiple emulsions for further in vivo applications. This 
long lasting versatile microchip now allows us to produce enough microdroplets to consider intravenous drug 
delivery studies in small animal models. We also showed that this system may be used for both simple and multiple 
emulsions production, and that depending on chemicals that are used, and especially on their viscosities, droplet 
characteristics may be well tuned if applied pressures are within defined ranges. Observations with a high-speed 
camera were also realized in order to better understand microscale phenomenon governing droplet formation at a 
micron scale. Lastly, changing production technique and device did not altered acoustic vaporization properties of 
microdroplets, which remain inducible by a clinical ultrasound scanner. 
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Supplementary 
 
Fig. SI 1 PFH droplet PDI as a function of capillary numbers ratio 
 
 
Fig. SI 2 Droplet mean diameters (left) and PDI (right) as a function of capillary number ratio for increasing values 
of continuous phase viscosity 
 
Fig. SI 3 Droplet mean diameter (left) and PDI (right) as a function of flow rate ratio for increasing values of 
continuous phase viscosity 
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Fig. SI 4 Production rate of multiple emulsions: amount of microdroplets produced with different applied pressures 
for emulsions of W/PFH/W. Production rate is proportional to circle diameters, while standard deviation is 
proportional to line width 
 
 
Fig. SI 5 W/PFH/W droplet PDI as a function of capillary numbers ratio. Dripping regime takes place for capillary 
ratios inferior to 10-8 while blow-up regime takes place above this critical value 
 
